Global X S&P Biotech ETF
CURE
- A$42.18
- 2.1
- 5.24%
Global X S&P Biotech ETF CURE Strategy
The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index.
The investment objective & strategy is a summary of the investment's principal strategy as written in the prospectus. This information is pulled from the most recent product disclosure document.
ETFs News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,125.20 | 111.50 | 1.39% |
| CAC 40 | 7,511.35 | 184.88 | 2.52% |
| DAX 40 | 21,959.49 | 665.96 | 3.13% |
| Dow JONES (US) | 40,245.92 | 1,058.94 | 2.70% |
| FTSE 100 | 8,427.73 | 99.13 | 1.19% |
| HKSE | 22,072.62 | 510.30 | 2.37% |
| NASDAQ | 16,968.19 | 667.77 | 4.10% |
| Nikkei 225 | 34,868.63 | 648.03 | 1.89% |
| NZX 50 Index | 11,956.47 | 119.78 | 1.01% |
| S&P 500 | 5,455.24 | 167.48 | 3.17% |
| S&P/ASX 200 | 7,920.50 | 103.80 | 1.33% |
| SSE Composite Index | 3,296.36 | 3.40 | -0.10% |